JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on July 13, 2006; DOI: 10.1124/jpet.106.104380


0022-3565/06/3191-165-180$20.00
JPET 319:165-180, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.104380v1
319/1/165    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, D.-M.
Right arrow Articles by Zhu, X.-Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, D.-M.
Right arrow Articles by Zhu, X.-Z.

NEUROPHARMACOLOGY

Involvement of Multitargets in Paeoniflorin-Induced Preconditioning

Dong-Mei Chen, Liang Xiao, Xin Cai, Rong Zeng, and Xing-Zu Zhu

Department of Pharmacology, Shanghai Institute of Materia Medica (D.-M.C., X.C., X.-Z.Z.) and The Research Centre for Proteome Analysis, Key Lab of Proteomics, Institute of Biochemistry and Cell Biology (R.Z.), Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China; and Department of Research and Development (L.X.), Jiangsu Hengrui Medicine Company, Shanghai, China

Paeoniflorin (PF) is the principal component of Paeoniae radix prescribed in traditional Chinese medicine. The delayed neuroprotection induced by PF preconditioning and its underlying mechanisms were investigated in rat middle cerebral artery occlusion (MCAO) and reperfusion model. At a dosage of 20 or 40 mg/kg, PF preconditioning 48 h before MCAO followed by 24-h reperfusion significantly reduced the mortality and infarct volume and reversed the neurological deficits caused by ischemia. Likewise, the ameliorative effects on mortality, infarct size, and neurological impairment induced by MCAO emerged as well when PF was administered 24 h, 48 h, or 5 days before MCAO at the dose of 20 mg/kg. Furthermore, comparative proteomics analysis was adopted to identify the differentially expressed proteins induced by PF preconditioning itself. The relative levels of 42 proteins were altered after PF preconditioning, among which 20 were elevated and 22 reduced. In summary, A1 receptor-regulator of G protein signaling-KATP signaling, arachidonic acid cascade, nitric oxide system, markers of neuronal damage, mitochondrial damage-related molecules, and the mitogen-activated protein kinase and nuclear factor-{kappa}B pathway are associated with the mechanisms of PF preconditioning.


Received for publication March 10, 2006
Accepted July 12, 2006.

Address correspondence to: Dr. Xing-Zu Zhu, Department of Pharmacology, Shanghai Institute of Materia Medica, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Zhangjiang Hi-Tech Park, Pudong Shanghai 201203, China. E-mail: xzzhu{at}mail.shcnc.ac.cn







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.